DCF — MERCYONE NORTH IOWA MEDICAL CENTER
Enterprise Value: $-345.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-345.2M
Enterprise Value
$-115.5M
PV of Cash Flows
$-229.7M
PV of Terminal Value
$-370.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $402.1M | $-18.1M | -5.0% | $-35.1M | $-31.9M |
| Year 2 | $414.1M | $-14.5M | -4.0% | $-32.0M | $-26.5M |
| Year 3 | $426.5M | $-10.7M | -3.0% | $-28.7M | $-21.6M |
| Year 4 | $439.3M | $-8.8M | -2.0% | $-27.4M | $-18.7M |
| Year 5 | $452.5M | $-7.9M | -2.0% | $-27.1M | $-16.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-345.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$390.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000051236837
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5